Zobrazeno 1 - 10
of 1 333
pro vyhledávání: '"Winckler, S."'
Autor:
Tara Garnett
Publikováno v:
Animal Welfare. 17:412-414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b240a93880633d282515d1f52bc382f
https://doi.org/10.1017/s0962728600027998
https://doi.org/10.1017/s0962728600027998
Publikováno v:
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2022 Jan-Feb; Vol. 62 (1), pp. 288-295.e2. Date of Electronic Publication: 2021 Jun 11.
Autor:
De Bruyne B, Fearon WF, Pijls NH, Tonino P, Piroth Z, Jagic N, Mobius Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstr?m T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, N?esch E, J?ni P, FAME 2 Trial Investigators, BARBATO, EMANUELE
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (13), pp.1208-17. ⟨10.1056/NEJMoa1408758⟩
De Bruyne, Bernard; Fearon, William F; Pijls, Nico H J; Barbato, Emanuele; Tonino, Pim; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Riouffol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engström, Thomas; Oldroyd, Keith; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B; ... (2014). Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease. New England journal of medicine NEJM, 371(13), pp. 1208-1217. Massachusetts Medical Society MMS 10.1056/NEJMoa1408758
FAME 2 Trial Investigators 2014, ' Fractional flow reserve-guided PCI for stable coronary artery disease ', New England Journal of Medicine, vol. 371, no. 13, pp. 1208-1217 . https://doi.org/10.1056/NEJMoa1408758
The New England Journal of Medicine, 371(13), 1208-1217. Massachussetts Medical Society
New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (13), pp.1208-17. ⟨10.1056/NEJMoa1408758⟩
De Bruyne, Bernard; Fearon, William F; Pijls, Nico H J; Barbato, Emanuele; Tonino, Pim; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Riouffol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engström, Thomas; Oldroyd, Keith; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B; ... (2014). Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease. New England journal of medicine NEJM, 371(13), pp. 1208-1217. Massachusetts Medical Society MMS 10.1056/NEJMoa1408758
FAME 2 Trial Investigators 2014, ' Fractional flow reserve-guided PCI for stable coronary artery disease ', New England Journal of Medicine, vol. 371, no. 13, pp. 1208-1217 . https://doi.org/10.1056/NEJMoa1408758
The New England Journal of Medicine, 371(13), 1208-1217. Massachussetts Medical Society
International audience; BACKGROUND: We hypothesized that in patients with stable coronary artery disease and stenosis, percutaneous coronary intervention (PCI) performed on the basis of the fractional flow reserve (FFR) would be superior to medical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121c87577e3d9e86627f06afc7e0ec8e
https://hal.archives-ouvertes.fr/hal-01859382
https://hal.archives-ouvertes.fr/hal-01859382
Autor:
Stewart M; Friends of Cancer Research, Washington, District of Columbia, United States of America., Rodriguez-Watson C; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Albayrak A; Health Catalyst, Salt Lake City, Utah, United States of America., Asubonteng J; Gilead Science, Inc. Foster City, California, United States of America., Belli A; COTA, Inc., Boston, Massachusetts, United States of America., Brown T; Syapse, San Francisco, California, United States of America., Cho K; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Das R; Dascena, Oakland, California, United States of America., Eldridge E; Health Catalyst, Salt Lake City, Utah, United States of America., Gatto N; Aetion, New York, New York, United States of America., Gelman A; Health Catalyst, Salt Lake City, Utah, United States of America., Gerlovin H; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Goldberg SL; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America., Hansen E; COTA, Inc., Boston, Massachusetts, United States of America., Hirsch J; Syapse, San Francisco, California, United States of America., Ho YL; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Ip A; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America., Izano M; Syapse, San Francisco, California, United States of America., Jones J; Health Catalyst, Salt Lake City, Utah, United States of America., Justice AC; VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.; Yale University Schools of Medicine and Public Health, New Haven, Connecticut, United States of America., Klesh R; HealthVerity, Philadelphia, Pennsylvania, United States of America., Kuranz S; TriNetX, Cambridge, Massachusetts, United States of America., Lam C; Dascena, Oakland, California, United States of America., Mao Q; Dascena, Oakland, California, United States of America., Mataraso S; Dascena, Oakland, California, United States of America., Mera R; Gilead Science, Inc. Foster City, California, United States of America., Posner DC; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Rassen JA; Aetion, New York, New York, United States of America., Siefkas A; Dascena, Oakland, California, United States of America., Schrag A; Syapse, San Francisco, California, United States of America., Tourassi G; National Center for Computational Sciences Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America., Weckstein A; Aetion, New York, New York, United States of America., Wolf F; Syapse, San Francisco, California, United States of America., Bhat A; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Winckler S; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Sigal EV; Friends of Cancer Research, Washington, District of Columbia, United States of America.; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Allen J; Friends of Cancer Research, Washington, District of Columbia, United States of America.
Publikováno v:
PloS one [PLoS One] 2021 Mar 17; Vol. 16 (3), pp. e0248128. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Autor:
Metwali A; Internal Medicine, Iowa City Veterans Administration Health Center, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA, USA., Winckler S; Internal Medicine, Iowa City Veterans Administration Health Center, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA, USA., Urban JF Jr; U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Diet, Genomics, and Immunology Laboratory, Beltsville, MD, USA., Kaplan MH; Department of Pediatrics, H.B. Wells Center for Pediatric Research and Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA., Ince MN; Internal Medicine, Iowa City Veterans Administration Health Center, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA, USA., Elliott DE; Internal Medicine, Iowa City Veterans Administration Health Center, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA, USA.
Publikováno v:
European journal of immunology [Eur J Immunol] 2021 Feb; Vol. 51 (2), pp. 433-444. Date of Electronic Publication: 2020 Nov 18.
Publikováno v:
Zeitschrift fur Orthopadie und Ihre Grenzgebiete; 20240101, Issue: Preprints
Biopharmaceuticals such as antibodies are produced in cultivated mammalian cells, which must be monitored to comply with good manufacturing practice. We, therefore, developed a fully automated system comprising a specific exhaust gas analyzer, inline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::7cfbf3a9a4ab995b3b22ee7b3e180e9d
https://publica.fraunhofer.de/handle/publica/236336
https://publica.fraunhofer.de/handle/publica/236336
Autor:
Xiang, Zhichu1,2 (AUTHOR), Lu, Jianhua1 (AUTHOR), Ming, Yang2 (AUTHOR), Guo, Weisheng3 (AUTHOR) guo_wei_sheng@gzhmu.edu.cn, Chen, Xiaoyuan2,4,5,6,7 (AUTHOR) chen.shawn@nus.edu.sg, Sun, Weijian1 (AUTHOR) weijiansun@wmu.edu.cn
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-10. 10p.
Autor:
du Toit, Carla J.1,2 (AUTHOR) cdt304@gmail.com, Chinsamy, Anusuya2 (AUTHOR), Cunningham, Susan J.1,2 (AUTHOR)
Publikováno v:
Journal of Avian Biology. Sep/Oct2024, Vol. 2024 Issue 9/10, p1-12. 12p.